ArticleNeuro-oncology2025

Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.

Thomas J Kaley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.